Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
Clinical trial NCT02112578 · COMPLETED
Trial details
- NCT number
- NCT02112578
- Sponsor
- Apsen Farmaceutica S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-04-01
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.